title: Remission of nephrotic syndrome due to AA-amyloidosis, complicating familiar Mediterranean fever, with tocilizumab.
authors.affiliation: Department of Internal Medicine and Clinical Immunology, Euroclinic Hospital, Athens, Greece.
authors.forename: John
authors.initials: J
authors.lastname: Serelis
authors.affiliation: Department of Internal Medicine and Clinical Immunology, Euroclinic Hospital, Athens, Greece.
authors.forename: Sophia
authors.initials: S
authors.lastname: Christaki
authors.affiliation: Department of Internal Medicine and Clinical Immunology, Euroclinic Hospital, Athens, Greece. fskopouli@euroclinic.gr.
authors.forename: Fotini N
authors.initials: FN
authors.lastname: Skopouli
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D010505:Familial Mediterranean Fever / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D011247:Pregnancy; D012074:Remission Induction; D000685:Serum Amyloid A Protein / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers; D007166:Immunosuppressive Agents; D000685:Serum Amyloid A Protein; C502936:tocilizumab